Technologies

Medical Sciences

Title:

Clinical Decision Support Tool for Pre-emptive Screening of Alzheimer’s Disease

Area:

Medical Sciences

Focus Area:

Frugal Innovation, Health

Status:

Proof of Concept established

Patent:

In the process of filing

Social Benefits:

Early identification and management of the risk for Alzheimer’s in adult life will have a profound impact. Our platform aims to provide early detection and management of Alzheimer's risk, significantly reducing the disease burden and prolonging independence for individuals. By offering a cost-effective and efficient solution, it ensures rapid diagnosis and treatment, thereby revolutionizing elderly care and contributing to improved overall well-being in the aging population.

Developing Agency:

NeuroRhythm LLP, West Bengal

Technology Readiness Index:

TRL 3

Brief Description

Description :

The product will be essentially an AI -based holistic risk prediction platform for early stage Alzheimer’s disease detection. Product incorporates two separate component- a) A salivary Lactoferrin (biomarker) detection kit & b) AI-based risk propensity prediction platform

Related Technologies